Manufacturers/Nephron Pharmaceuticals Corporation

Nephron Pharmaceuticals Corporation

24 drugs in NADAC|23 Generic,1 Brand

Nephron Pharmaceuticals Corporation lists 24 NDCs in the CMS NADAC file (23 generic, 1 brand), at an average NADAC of $0.26 per unit, with a week-over-week move of -1.1% across products that moved. The firm's full portfolio, pricing trend, and FDA recalls are listed below.

Total Drugs

23G / 1B

Avg Price / Unit

$0.2556

$0.03 – $0.75

Avg 7d Change

-1.08%

Across 19 drugs with changes

7d Activity

8↑11↓5 flat

of 24 total drugs

Portfolio Price Trend

Monthly average NADAC price across all drugs

Keep following this manufacturer

These next-step links connect the manufacturer page to the markets, classes, and trend views most likely to deepen research.

Lead market

Albuterol Sulfate market

See the molecule this manufacturer shows up in most often and compare it against competing suppliers.

Lead class

beta2-Adrenergic Agonist therapeutic class

Review the broader class where Nephron Pharmaceuticals Corporation has the strongest current portfolio footprint.

Trend hub

Portfolio trend view

Jump to the trend hub to compare this manufacturer against the rest of the market on weekly price movement.

Guide

NADAC pricing primer

Use the explainer for context on the benchmark this manufacturer is being compared against.

Frequently Asked Questions

How many drugs does Nephron Pharmaceuticals Corporation make?

Nephron Pharmaceuticals Corporation lists 24 NDCs in the CMS NADAC file — 23 generic and 1 brand product.

What is the average price of Nephron Pharmaceuticals Corporation drugs?

The average NADAC across Nephron Pharmaceuticals Corporation's portfolio is $0.2556 per unit, ranging from $0.0262 to $0.7541.

What types of drugs does Nephron Pharmaceuticals Corporation make?

Nephron Pharmaceuticals Corporation makes drugs across 3 FDA pharmacologic classes. The most common by NDC count are beta2-Adrenergic Agonist (13), Anticholinergic (9), Corticosteroid (4).

Has Nephron Pharmaceuticals Corporation had any drug recalls?

6 FDA recalls are matched to Nephron Pharmaceuticals Corporation in the openFDA feed, most recently on Oct 21, 2019.

How has Nephron Pharmaceuticals Corporation's pricing changed recently?

Over the past 7 days, 8 Nephron Pharmaceuticals Corporation products rose and 11 fell, with a portfolio-wide average change of -1.1%.

Drug Portfolio

24 drugs total, 24 shown

Drug ↕	NDC	Price	7d Change ↕	Class	Market Outlier	Therapeutic Class
ASTHMANEFRIN RFILL 2.25% SOLN racepinephrine hydrochloride	00487278401	$0.7541 per EA	—	Brand OTC	—	—
BUDESONIDE 0.25 MG/2 ML SUSP BUDESONIDE	00487960101	$0.6974 per ML	-3.11%	Generic	—	Corticosteroid
BUDESONIDE 0.25 MG/2 ML SUSP BUDESONIDE	00487960130	$0.6974 per ML	-3.11%	Generic	—	Corticosteroid
BUDESONIDE 0.5 MG/2 ML SUSP BUDESONIDE	00487970101	$0.6761 per ML	-3.89%	Generic	—	Corticosteroid
BUDESONIDE 0.5 MG/2 ML SUSP BUDESONIDE	00487970130	$0.6761 per ML	-3.89%	Generic	—	Corticosteroid
ALBUTEROL 2.5 MG/0.5 ML SOL Albuterol Sulfate	00487990130	$0.5158 per EA	-2.12%	Generic	—	beta2-Adrenergic Agonist
ALBUTEROL 2.5 MG/0.5 ML SOL Albuterol Sulfate	00487990102	$0.3616 per EA	—	Generic	—	beta2-Adrenergic Agonist
ALBUTEROL SUL 0.63 MG/3 ML SOL Albuterol Sulfate	00487030101	$0.2523 per ML	+0.71%	Generic	—	beta2-Adrenergic Agonist
ALBUTEROL SUL 1.25 MG/3 ML SOL Albuterol Sulfate	00487990401	$0.2262 per ML	+2.79%	Generic	—	beta2-Adrenergic Agonist
ALBUTEROL SUL 1.25 MG/3 ML SOL Albuterol Sulfate	00487990425	$0.1979 per ML	+0.03%	Generic	—	beta2-Adrenergic Agonist
IPRATROPIUM BR 0.02% SOLN Ipratropium Bromide	00487980130	$0.1122 per ML	-1.48%	Generic	—	Anticholinergic
IPRATROPIUM BR 0.02% SOLN Ipratropium Bromide	00487980101	$0.1122 per ML	-1.48%	Generic	—	Anticholinergic
IPRATROPIUM BR 0.02% SOLN Ipratropium Bromide	00487980160	$0.1099 per ML	+0.94%	Generic	—	Anticholinergic
IPRATROPIUM BR 0.02% SOLN Ipratropium Bromide	00487980125	$0.1040 per ML	-2.16%	Generic	—	Anticholinergic
IPRATROPIUM-ALBUTEROL 0.5-3(2.5) MG/3 ML Ipratropium Bromide and Albuterol Sulfate	00487020160	$0.0832 per ML	-2.69%	Generic	Low Outlier	Anticholinergic, beta2-Adrenergic Agonist
IPRATROPIUM-ALBUTEROL 0.5-3(2.5) MG/3 ML Ipratropium Bromide and Albuterol Sulfate	00487020101	$0.0787 per ML	-3.09%	Generic	Low Outlier	Anticholinergic, beta2-Adrenergic Agonist
IPRATROPIUM-ALBUTEROL 0.5-3(2.5) MG/3 ML Ipratropium Bromide and Albuterol Sulfate	00487020103	$0.0787 per ML	-3.09%	Generic	Low Outlier	Anticholinergic, beta2-Adrenergic Agonist
IPRATROPIUM-ALBUTEROL 0.5-3(2.5) MG/3 ML Ipratropium Bromide and Albuterol Sulfate	00487020102	$0.0723 per ML	—	Generic	Low Outlier	Anticholinergic, beta2-Adrenergic Agonist
ALBUTEROL SUL 2.5 MG/3 ML SOLN Albuterol Sulfate	00487950160	$0.0665 per ML	+1.13%	Generic	—	beta2-Adrenergic Agonist
ALBUTEROL SUL 2.5 MG/3 ML SOLN Albuterol Sulfate	00487950103	$0.0612 per ML	+1.19%	Generic	—	beta2-Adrenergic Agonist
ALBUTEROL SUL 2.5 MG/3 ML SOLN Albuterol Sulfate	00487950101	$0.0612 per ML	+1.19%	Generic	—	beta2-Adrenergic Agonist
ALBUTEROL SUL 2.5 MG/3 ML SOLN Albuterol Sulfate	00487950125	$0.0604 per ML	+1.70%	Generic	—	beta2-Adrenergic Agonist
IPRATROPIUM BR 0.02% SOLN Ipratropium Bromide	00487980102	$0.0529 per ML	—	Generic	—	Anticholinergic
SODIUM CHLORIDE 0.9% SOLUTION Sodium Chloride	00487430110	$0.0262 per ML	—	Generic	—	—

FDA Recalls (6)

Recalls matched by company name. Verify current status with FDA.

D-0154-2020 →

Terminated

Class III

PF-Succinylcholine Chloride Injection, USP 20 mg/mL (200 mg/10 mL), Rx Only, Single-Dose Container, 5 x 10 mL pre-filled syringes, Nephron 503B Outsourcing Facility 4500 12th St. Ext West Columbia, SC 29172, NDC 69374-919-10.

Incorrect labeling: Incorrect or missing lot and/or exp date

Initiated: 10/21/2019

D-0150-2020 →

Terminated

Class II

Amino Acid Injection 50 g/1000 mL (50 mg/mL) 25 g L-Arginine HCl; 25 g L-Lysine HCl, Single Dose Container, Rx Only Nephron 503B outsourcing facility 4500 12th St. Extension West Columbia, SC 29172 NDC: 69374-988-10

Lack of Assurance of Sterility; bags have potential to leak

Initiated: 10/9/2019

D-0148-2020 →

Terminated

Class II

PF-Fentanyl Citrate 2 mcg/mL* & Bupivacaine HCl 0.125% in 0.9% Sodium Chloride Injection-250 mL, Rx Only Total Dose: (500 mcg/312.5 mg)/250 mL, Nephron 503B Outsourcing Facility 4500 12th St. Extension West Columbia, SC 29172 NDC: 69374-530-25

GMP Deviations: potential glass contamination

Initiated: 10/9/2019

D-0147-2020 →

Terminated

Class II

PF-Fentanyl Citrate (2 mcg/mL)* & Bupivacaine HCl 0.0625 in 0.9% Sodium Chloride Injection-250 mL Total Dose: (500 mcg/156.3 mg)/250 mL, Rx Only, Nephron 503B Outsourcing Facility 4500 12th St. Extension West Columbia, SC 29172 NDC 69374-0525-25

GMP Deviations: potential glass contamination

Initiated: 10/9/2019

D-0151-2020 →

Terminated

Class II

del Nido Cardioplegia Solution, 1000 mL, Single-Dose Container, Rx Only Nephron 503B Outsourcing Facility 4500 12th St. Extension West Columbia, SC 29172 NDC: 69374-984-10

Lack of Assurance of Sterility; bags have potential to leak

Initiated: 10/9/2019

D-0149-2020 →

Terminated

Class II

PF-Fentanyl Citrate 2 mcg/mL* & Ropivacaine HCl 0.1% in 0.9% Sodium Chloride Injection-200 mL Total Dose: (400 mcg/200 mg)/200 mL, Rx Only Nephron 503B Outsourcing Facility 4500 12th St. Extension West Columbia, SC 29172 NDC: 69374-526-20

GMP Deviations: potential glass contamination

Initiated: 10/9/2019